| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6010
|
15.22 | 4.6B | 12.18 | 1.00 | 3.74 | 7.8% | 11.2% | 74 | 60 | 29.26 | +69.2% | 87 | 0.12 |
|
2050
|
26.20 | 7.8B | 0.78 | 1.47 | 0.94 | 7.8% | 10.4% | 71 | 48 | 54.04 | +71.2% | 59 | 1.14 |
|
2270
|
205.90 | 6.6B | 13.78 | 3.78 | 9.73 | 25.2% | 12.0% | 63 | 55 | 179.55 | -9.6% | 98 | 0.04 |
|
2280
|
48.10 | 48.1B | 19.58 | 2.34 | 10.99 | 8.3% | 8.9% | 57 | 43 | 42.45 | -8.8% | 64 | 0.64 |
|
2120
|
16.80 | 991.2M | — | 0.94 | — | -12.6% | 12.5% | 52 | 20 | 34.98 | +52.0% | 77 | 0.14 |
|
2110
|
188.30 | 1.3B | 11.69 | — | — | — | — | 45 | 41 | 256.87 | +15.7% | 28 | -0.34 |
|
6020
|
12.42 | 372.6M | 26.54 | 1.22 | 522.02 | -0.2% | 15.5% | 42 | 17 | 8.59 | -19.7% | 67 | 0.00 |
|
2100
|
22.48 | 520.4M | — | 2.38 | — | -10.5% | 13.2% | 33 | 26 | 17.79 | -10.0% | 71 | 0.10 |
|
2130
|
16.02 | 480.6M | — | 8.89 | — | -11.1% | 12.9% | 19 | 14 | 4.00 | -32.3% | 39 | 0.85 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.